NCT02973412Recruiting
Chronotype of Patients With Diabetes and Effect on Glycaemic Control
Chronotype of Patients With Diabetes and Effect on Glycaemic Control: The CODEC Study
Source: ClinicalTrials.gov · Last updated 15 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3447 (estimated)
- First submitted
- 26 Oct 2016
- Start date
- 7 Dec 2016
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- University of Leicester
- Diseases
- Type 1 diabetes, Type 2 diabetes
- NCT number
- NCT02973412
What you commit to
- Study type: Observational
- Planned participants: 3447
- From 7 Dec 2016 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have a terminal illness
- A known sleep disorder that is not OSA
- Regular use of the following medicines i.e. Weekly use: (Wakefulness promoting agents Modafinil, Amphetamine derivatives, Methylphenidate; Sedatives including benzodiazepines, Z-drugs (zopiclone, zolpidem \& zaleplon); Melatonin, including Circadin and melatonin analogues; Clonazepam and other drugs for nocturnal movement disorders).
Age
- Anyone \<18 years of age and \>75 years of age
Other
- Participant is unwilling or unable to give informed consent
- Anyone without a good command of the English language
- BMI greater than 45 kg/m²
- A regular cannabis user i.e. weekly use
Who the study is looking for
- Participant is willing and able to give informed consent for participation in the study
- T1DM or established T2DM (\>6months since diagnosis)
- Male or Female
- Aged 18-75 years inclusive
- BMI less than or equal to 45kg/m² inclusive
- No known sleep disorders except Obstructive Sleep Apnoea (OSA)
- On any glucose-lowering therapy (T1DM or T2DM) or lifestyle modification for management of T2DM
- Good command of the English language
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Leicester Diabetes Centre, Leicester General Hospital Coordinator of this site? Confirm its status | Leicester | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.